Reuters - Sanofi-Aventis SA's obesity pill
Acomplia faces a tough review from European drug safety experts
this week, with data suggesting officials see issues over the
drug's link with suicidal thoughts.
Source: http://rss.news.yahoo.com
Monday, July 16, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment